Gate Bioscience

Gate Bioscience is a preclinical biotechnology company based in Brisbane, California. The company employs 17 people. Gate Bioscience is developing a new class of medicines called Molecular Gates. These small molecule drugs target harmful extracellular proteins, selectively eliminating them at their source within the cell. The company aims to treat diseases by addressing the root cause of protein dysfunction. Molecular Gates operate through a novel therapeutic mechanism. They bind to a single channel through which all extracellular proteins pass during secretion. By acting as a "gate," they block the release of specific disease-causing proteins, leading to their degradation within the cell. For more information about Gate Bioscience and its innovative approach to medicine, visit www.gatebio.com.